Leonard Reyno

Leonard Reyno

Company: Pionyr Immunotherapeutics

Job title: Chief Executive Officer

Bio:

Prior to joining Pionyr, Leonard Reyno was EVP and Chief Medical Officer at ORIC Pharmaceuticals leading the introduction of their first product candidate into human trials. Before that, he served as Senior Vice President and Chief Medical Officer at Agensys, a subsidiary of Astellas Pharma, where he led clinical stage development of multiple antibody products to novel targets through clinical proof of concept of multiple products. Dr. Reyno’s prior positions in industry included Global Medical Director for Taxotere/Breast cancer at Aventis, Medical Director and Lead Clinical Scientist for Herceptin at Genentech and Senior Director of Oncology at Cytokinetics. Before joining industry, Dr. Reyno was an academic oncologist, where he had both extensive experience as a clinician (especially in breast and genitor-urinary malignancy) as well as serving as Principal Investigator on multiple trials with the National Cancer Institute of Canada.

Seminars:

Panel Discussion – Exploring Key Clinical Considerations for Macrophage-directed Therapies 3:45 pm

Download The Full Event Guide Read more

day: Day Two

Relearning the Biology of Macrophages in Tumors to Accelerate Development of Next Generation Anti-Tumor Treatment 10:45 am

Download The Full Event Guide Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.